FDA Inspection
Pfizer Asia Manufacturing Pte Ltd.Pfizer Asia Manufacturing Pte Ltd. – FDA Inspection, Mar 15, 2019
Record Details
This FDA Inspection record concerns Pfizer Asia Manufacturing Pte Ltd., with an inspection on March 15, 2019, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 7d96dea7-3b07-46be-8bd4-730b14818479
Inspection Facts
- Inspection number
- 1085293
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Pfizer Asia Manufacturing Pte Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| October 27, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 3, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 1, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 19, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pfizer Asia Manufacturing Pte Ltd.
- FDA Inspection 1156359 - 2021-10-27
- FDA Inspection 1009110 - 2017-03-24
- FDA Inspection 955761 - 2015-12-03
- FDA Inspection 825350 - 2013-03-01
- FDA Inspection 580783 - 2009-03-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.